As part of the Antibiotic Resistance Solutions Initiative, CDC recently awarded $9 million to pilot innovative solutions and explore knowledge gaps about antibiotic resistance related to the human microbiome, healthcare settings, and surface water and soil. DSTDP’s funded project focuses on point-of-care antibiotic susceptibility testing for gonorrhea. CDC and investigators will develop and evaluate new molecular assays that can determine the antibiotics to which a patient’s strain of gonorrhea is susceptible. This fast and efficient test will help guide individual patient management and can be used to identify antibiotic-resistant strains of gonorrhea using molecular techniques rather than culture. It can also be used to support outbreak investigations of resistant gonorrhea in the community.